Cryoablation of unresectable pancreatic cancer

Stephen J. Kovach, Richard J. Hendrickson, Charles R. Cappadona, C. Schmidt, Kara Groen, Leonidas Koniaris, James V. Sitzmann

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

Background. Most patients with pancreatic cancer are not candidates for curative resection. The goal of this study was to evaluate the safety of an intraoperative ultrasound-guided cryosurgical procedure in a phase I study of unresectable pancreatic cancer. Methods. From March 1995 to March 1999, 10 cryosurgeries using intraoperative ultrasound were performed on 9 patients with unresectable cancers at laparotomy. Four patients had a concurrent gastrojejunostomy, 2 had a chemical splanchnicectomy, and 1 underwent a concurrent hepatic cryosurgical procedure. Results. There was no intraoperative morbidity or mortality. No patients developed postoperative pancreatitis or fistula. All patients had good pain control postoperatively and were tolerating a regular diet at the time of discharge. Pain control at discharge was achieved with an oral formulation (4/9), transdermal patch (3/9), no pain medication (1/9), and intravenous patient controlled analgesia (1/9). Conclusions. Ultrasound-guided cryoablation for unresectable pancreatic cancer appears safe and may contribute to improved postoperative pain control. Future studies to determine its therapeutic role in the management of unresectable pancreatic cancer are indicated.

Original languageEnglish (US)
Pages (from-to)463-464
Number of pages2
JournalSurgery
Volume131
Issue number4
DOIs
StatePublished - 2002
Externally publishedYes

Fingerprint

Cryosurgery
Pancreatic Neoplasms
Pain
Transdermal Patch
Patient-Controlled Analgesia
Gastric Bypass
Postoperative Pain
Pancreatitis
Laparotomy
Fistula
Diet
Morbidity
Safety
Mortality
Liver
Neoplasms

ASJC Scopus subject areas

  • Surgery

Cite this

Kovach, S. J., Hendrickson, R. J., Cappadona, C. R., Schmidt, C., Groen, K., Koniaris, L., & Sitzmann, J. V. (2002). Cryoablation of unresectable pancreatic cancer. Surgery, 131(4), 463-464. https://doi.org/10.1067/msy.2002.121231

Cryoablation of unresectable pancreatic cancer. / Kovach, Stephen J.; Hendrickson, Richard J.; Cappadona, Charles R.; Schmidt, C.; Groen, Kara; Koniaris, Leonidas; Sitzmann, James V.

In: Surgery, Vol. 131, No. 4, 2002, p. 463-464.

Research output: Contribution to journalArticle

Kovach, SJ, Hendrickson, RJ, Cappadona, CR, Schmidt, C, Groen, K, Koniaris, L & Sitzmann, JV 2002, 'Cryoablation of unresectable pancreatic cancer', Surgery, vol. 131, no. 4, pp. 463-464. https://doi.org/10.1067/msy.2002.121231
Kovach SJ, Hendrickson RJ, Cappadona CR, Schmidt C, Groen K, Koniaris L et al. Cryoablation of unresectable pancreatic cancer. Surgery. 2002;131(4):463-464. https://doi.org/10.1067/msy.2002.121231
Kovach, Stephen J. ; Hendrickson, Richard J. ; Cappadona, Charles R. ; Schmidt, C. ; Groen, Kara ; Koniaris, Leonidas ; Sitzmann, James V. / Cryoablation of unresectable pancreatic cancer. In: Surgery. 2002 ; Vol. 131, No. 4. pp. 463-464.
@article{e667ad8d8a30448b8e08409eddbba30d,
title = "Cryoablation of unresectable pancreatic cancer",
abstract = "Background. Most patients with pancreatic cancer are not candidates for curative resection. The goal of this study was to evaluate the safety of an intraoperative ultrasound-guided cryosurgical procedure in a phase I study of unresectable pancreatic cancer. Methods. From March 1995 to March 1999, 10 cryosurgeries using intraoperative ultrasound were performed on 9 patients with unresectable cancers at laparotomy. Four patients had a concurrent gastrojejunostomy, 2 had a chemical splanchnicectomy, and 1 underwent a concurrent hepatic cryosurgical procedure. Results. There was no intraoperative morbidity or mortality. No patients developed postoperative pancreatitis or fistula. All patients had good pain control postoperatively and were tolerating a regular diet at the time of discharge. Pain control at discharge was achieved with an oral formulation (4/9), transdermal patch (3/9), no pain medication (1/9), and intravenous patient controlled analgesia (1/9). Conclusions. Ultrasound-guided cryoablation for unresectable pancreatic cancer appears safe and may contribute to improved postoperative pain control. Future studies to determine its therapeutic role in the management of unresectable pancreatic cancer are indicated.",
author = "Kovach, {Stephen J.} and Hendrickson, {Richard J.} and Cappadona, {Charles R.} and C. Schmidt and Kara Groen and Leonidas Koniaris and Sitzmann, {James V.}",
year = "2002",
doi = "10.1067/msy.2002.121231",
language = "English (US)",
volume = "131",
pages = "463--464",
journal = "Surgery",
issn = "0039-6060",
publisher = "Mosby Inc.",
number = "4",

}

TY - JOUR

T1 - Cryoablation of unresectable pancreatic cancer

AU - Kovach, Stephen J.

AU - Hendrickson, Richard J.

AU - Cappadona, Charles R.

AU - Schmidt, C.

AU - Groen, Kara

AU - Koniaris, Leonidas

AU - Sitzmann, James V.

PY - 2002

Y1 - 2002

N2 - Background. Most patients with pancreatic cancer are not candidates for curative resection. The goal of this study was to evaluate the safety of an intraoperative ultrasound-guided cryosurgical procedure in a phase I study of unresectable pancreatic cancer. Methods. From March 1995 to March 1999, 10 cryosurgeries using intraoperative ultrasound were performed on 9 patients with unresectable cancers at laparotomy. Four patients had a concurrent gastrojejunostomy, 2 had a chemical splanchnicectomy, and 1 underwent a concurrent hepatic cryosurgical procedure. Results. There was no intraoperative morbidity or mortality. No patients developed postoperative pancreatitis or fistula. All patients had good pain control postoperatively and were tolerating a regular diet at the time of discharge. Pain control at discharge was achieved with an oral formulation (4/9), transdermal patch (3/9), no pain medication (1/9), and intravenous patient controlled analgesia (1/9). Conclusions. Ultrasound-guided cryoablation for unresectable pancreatic cancer appears safe and may contribute to improved postoperative pain control. Future studies to determine its therapeutic role in the management of unresectable pancreatic cancer are indicated.

AB - Background. Most patients with pancreatic cancer are not candidates for curative resection. The goal of this study was to evaluate the safety of an intraoperative ultrasound-guided cryosurgical procedure in a phase I study of unresectable pancreatic cancer. Methods. From March 1995 to March 1999, 10 cryosurgeries using intraoperative ultrasound were performed on 9 patients with unresectable cancers at laparotomy. Four patients had a concurrent gastrojejunostomy, 2 had a chemical splanchnicectomy, and 1 underwent a concurrent hepatic cryosurgical procedure. Results. There was no intraoperative morbidity or mortality. No patients developed postoperative pancreatitis or fistula. All patients had good pain control postoperatively and were tolerating a regular diet at the time of discharge. Pain control at discharge was achieved with an oral formulation (4/9), transdermal patch (3/9), no pain medication (1/9), and intravenous patient controlled analgesia (1/9). Conclusions. Ultrasound-guided cryoablation for unresectable pancreatic cancer appears safe and may contribute to improved postoperative pain control. Future studies to determine its therapeutic role in the management of unresectable pancreatic cancer are indicated.

UR - http://www.scopus.com/inward/record.url?scp=0036216860&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036216860&partnerID=8YFLogxK

U2 - 10.1067/msy.2002.121231

DO - 10.1067/msy.2002.121231

M3 - Article

C2 - 11935137

AN - SCOPUS:0036216860

VL - 131

SP - 463

EP - 464

JO - Surgery

JF - Surgery

SN - 0039-6060

IS - 4

ER -